Astragaloside IV Reduces OxLDL-Induced BNP Overexpression by Regulating HDAC

Figure 6

Expression level of BNP protein in each group after inhibiting HDAC activity. (a) The fluorescence intensity level of HDAC in nuclei of blank control group, OxLDL intervention group, UF010, and OxLDL + UF010 groups. (b) Western blot results of BNP protein in blank control group, OxLDL intervention group, UF010, and OxLDL + UF010 groups (indicates  < 0.001; indicates  < 0.05; NS: no significance; n = 5).

(a)

(b)